Loading company…
START conducts cancer research and provides clinical trials and treatment services.
South Texas Accelerated Research Therapeutics, also known as START, is a cancer research company based in Texas. It conducts clinical research and Phase I trials and provides services including tumor profiling, targeted therapies, chemotherapy, surgery, and radiation. Its work covers cancers including bladder, breast, colon, lung, prostate, kidney, skin, and genitourinary cancers. Warburg Pincus acquired a majority stake in April 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in